BoneMRI, the world’s first imaging technique that visualizes both bone and soft-tissue from one imaging exam.
Now Healthcare professionals and patients in the USA can benefit from this radiation-free solution.
In an exclusive interview Ms. Harris explains how BoneMRI will impact the US market.
No radiation exposure & potentially assisting surgery planning and navigation are key benefits.
BoneMRI as a harmless, radiation-free alternative to classic CT to (re)evaluate fractures.
It is very appealing as a potential future technique for clinical practice.
Rik will lead the company into a new growth stage and accelerate its commercial deployment.
His experience and understanding of the medical device sector is critical for the next steps of MRIguidance.
Founders of BoneMRI explain how this technology was invented and how it integrates in the clinical workflow.
Learn about its properties and the benefits it provides for diagnosis and computer assisted surgery.
BoneMRI was found to be noninferior to CT for patients suffering from cervical radiculopathy.
The study was held by researchers Van der Kolk et al, from Isala Hospital in Zwolle, the Netherlands.
This certification expands the list of obtained regulatory achievements.
Requirements have been met for the development, production, distribution, installation and servicing of BoneMRI.
BoneMRI is now available in the UK market.
Ovidius’s expertise is developing market access pathways and commercialising novel medical devices and technologies.
Peter Seevinck, co-founder and CSO, has been appointed as interim CEO of the company.
He will succeed Roel Raatgever for the foreseeable future and assume responsibilities from January 2022.